[Role of particulate matter and small airways in treatment of asthma with inhalative fixcombinations].
Voshaar
T
T
Krankenhaus Bethanien Moers, Medizinische Klinik III, Schwerpunkt Pneumologie, Allergologie, Zentrum für Schlaf- und Beatmungsmedizin, Interdisziplinäres Lungenzentrum, 47441 Moers. th.voshaar@bethanien-moers.de
D000280:Administration, Inhalation; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D000336:Aerosols; D000403:Airway Resistance / Q000187:drug effects*; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D001249:Asthma / Q000188:drug therapy*; D001682:Biological Availability; D001993:Bronchodilator Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D006801:Humans; D010316:Particle Size; D019999:Pharmaceutical Solutions; D011208:Powders
D000318:Adrenergic beta-Agonists; D000336:Aerosols; D018927:Anti-Asthmatic Agents; D001993:Bronchodilator Agents; D019999:Pharmaceutical Solutions; D011208:Powders